132 related articles for article (PubMed ID: 38550823)
1. Super Bioavailable (SUBA) Itraconazole-Induced Galactorrhea-Could it be due to Hydroxypropyl Methylcellulose Phthalate?
Yadav S; Garai T; Ritu K; Sardana K
Indian Dermatol Online J; 2024; 15(2):342-343. PubMed ID: 38550823
[No Abstract] [Full Text] [Related]
2. IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
Patel NH; Sardana K; Shenoy MM; Rengasamy M; Khurana A; Ghate S; Venkata CK; Marfatiya Y; Bhunia D; Jayaraman J; Das A; Jain AK
Indian Dermatol Online J; 2024; 15(1):1-7. PubMed ID: 38283009
[TBL] [Abstract][Full Text] [Related]
3. MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses-A Multicenter, Open-Label, Randomized Comparative Trial.
Spec A; Thompson GR; Miceli MH; Hayes J; Proia L; McKinsey D; Arauz AB; Mullane K; Young JA; McGwin G; McMullen R; Plumley T; Moore MK; McDowell LA; Jones C; Pappas PG
Open Forum Infect Dis; 2024 Mar; 11(3):ofae010. PubMed ID: 38440302
[TBL] [Abstract][Full Text] [Related]
4. Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation.
Lindsay J; Sandaradura I; Wong K; Arthur C; Stevenson W; Kerridge I; Fay K; Coyle L; Greenwood M
J Antimicrob Chemother; 2017 Dec; 72(12):3414-3419. PubMed ID: 28961894
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital.
Abbotsford J; Foley DA; Goff Z; Bowen AC; Blyth CC; Yeoh DK
J Antimicrob Chemother; 2021 Jan; 76(1):249-252. PubMed ID: 32929460
[TBL] [Abstract][Full Text] [Related]
6. A novel highly bio-available itraconazole formulation (SUBA®-Itraconazole) for anti-fungal prophylaxis in lung transplant recipients.
Whitmore TJ; Yaw M; Lavender M; Musk M; Boan P; Wrobel J
Transpl Infect Dis; 2021 Aug; 23(4):e13587. PubMed ID: 33590676
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies.
Nield B; Larsen SR; van Hal SJ
J Antimicrob Chemother; 2019 Oct; 74(10):3049-3055. PubMed ID: 31360992
[TBL] [Abstract][Full Text] [Related]
8. Effects of Food and Omeprazole on a Novel Formulation of Super Bioavailability Itraconazole in Healthy Subjects.
Lindsay J; Mudge S; Thompson GR
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297369
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of Single-Dose SUBA-Itraconazole Compared to Conventional Itraconazole under Fasted and Fed Conditions.
Rauseo AM; Mazi P; Lewis P; Burnett B; Mudge S; Spec A
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0013421. PubMed ID: 34031053
[TBL] [Abstract][Full Text] [Related]
10. Characterization of impurities formed by interaction of duloxetine HCl with enteric polymers hydroxypropyl methylcellulose acetate succinate and hydroxypropyl methylcellulose phthalate.
Jansen PJ; Oren PL; Kemp CA; Maple SR; Baertschi SW
J Pharm Sci; 1998 Jan; 87(1):81-5. PubMed ID: 9452973
[TBL] [Abstract][Full Text] [Related]
11. [Recurrent tinea corporis generalisata due to Terbinafine-resistant Trichophyton rubrum strain : Long-term treatment with super bioavailability itraconazole].
Nenoff P; Stahl M; Schaller M; Burmester A; Monod M; Ebert A; Uhrlaß S
Dermatologie (Heidelb); 2023 Nov; 74(11):864-873. PubMed ID: 37823916
[TBL] [Abstract][Full Text] [Related]
12. Application of hydroxypropyl methylcellulose as a protective agent against magnesium stearate induced crystallization of amorphous itraconazole.
Démuth B; Galata DL; Balogh A; Szabó E; Nagy B; Farkas A; Hirsch E; Pataki H; Vigh T; Mensch J; Verreck G; Nagy ZK; Marosi G
Eur J Pharm Sci; 2018 Aug; 121():301-308. PubMed ID: 29902510
[TBL] [Abstract][Full Text] [Related]
13. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
Solanki NG; Kathawala M; Serajuddin ATM
J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437
[TBL] [Abstract][Full Text] [Related]
14. Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults.
Thompson GR; Lewis P; Mudge S; Patterson TF; Burnett BP
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32457106
[TBL] [Abstract][Full Text] [Related]
15. Super Bioavailable Itraconazole and Its Place and Relevance in Recalcitrant Dermatophytosis: Revisiting Skin Levels of Itraconazole and Minimum Inhibitory Concentration Data.
Sardana K; Mathachan SR
Indian Dermatol Online J; 2021; 12(1):1-5. PubMed ID: 33768016
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy Volunteers.
Abuhelwa AY; Mudge S; Upton RN; Foster DJR
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):201-215. PubMed ID: 30328059
[TBL] [Abstract][Full Text] [Related]
17. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion. II: Rheological Analysis and Extrudability Testing.
Solanki NG; Gumaste SG; Shah AV; Serajuddin ATM
J Pharm Sci; 2019 Sep; 108(9):3063-3073. PubMed ID: 31103788
[TBL] [Abstract][Full Text] [Related]
18. A novel intravaginal delivery system for itraconazole: in vitro and in vivo evaluation.
Dobaria NB; Mashru RC; Badhan AC; Thakkar AR
Curr Drug Deliv; 2009 Apr; 6(2):151-8. PubMed ID: 19450221
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Grades of HPMCAS Spray Dried Dispersions of Itraconazole Based on Supersaturation Kinetics and Molecular Interactions Impacting Formulation Performance.
Adhikari A; Polli JE
Pharm Res; 2020 Sep; 37(10):192. PubMed ID: 32914239
[TBL] [Abstract][Full Text] [Related]
20. SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation.
Lindsay J; Othman J; Kong Y; Yip A; Van Hal S; Larsen S; Bryant C; Gibson J; Kerridge I; Fay K; Stevenson W; Arthur C; Chen SCA; Kong DCM; Greenwood M; Pergam SA; Liu C; Slavin MA
Open Forum Infect Dis; 2021 Nov; 8(11):ofab502. PubMed ID: 35559121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
